BROOK GRAM: Open Payments
NPI 1740321090 · BELOIT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,390 in 61 payments from 11 companies in 2025. Trend: 2023 $18,583 · 2024 $5,847 · 2025 $1,390
Food & beverage: $1,290Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $358 |
| Janssen Biotech, Inc. | 14 | $340 |
| UCB, Inc. | 4 | $162 |
| Amgen Inc. | 6 | $127 |
| GENZYME CORPORATION | 5 | $117 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| Lilly USA, LLC | 4 | $92 |
| PFIZER INC. | 2 | $36 |
| Organon LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, Bimzelx, RINVOQ, OTEZLA, DUPIXENT, COSENTYX, EBGLYSS.
Industry payments across OH — which companies pay providers there.
